Hutcheson Sam, Pehrson Aimee, Gassert Robert B, Guffey Ethan, Shanahan Paul C, Sisk Laura, Patton Samuel, Solla Che Antonio
Department of Anesthesiology; University of Tennessee Graduate School of Medicine, Knoxville, TN, USA.
J Pain Res. 2025 Apr 28;18:2233-2240. doi: 10.2147/JPR.S495181. eCollection 2025.
Postoperative opioid-induced respiratory depression (POIRD) is a preventable perioperative cause of morbidity and mortality. A validated POIRD risk stratification tool could reduce these complications. 3 pre-existing validated opioid tools; and specific risk factors identified from these tools; were examined in this retrospective case-control study to determine if they could assess POIRD risk in patients discharged to hospital floors from the Post-Anesthesia Care Unit (PACU).
Our dataset includes 126 matched patients who underwent surgery at the University of Tennessee Medical Center from January 2019 to December 2021. All patients that were related to active traumas or burns were excluded from this study. Escalation of care secondary to respiratory failure (an increase in respiratory support with movement to an intensive care unit/stepdown unit or patient expiration secondary to respiratory failure) with and without naloxone administration was the primary endpoint; with the subgroup that received naloxone being the surrogate POIRD endpoint. Escalation of care secondary to respiratory failure; regardless of naloxone use; was a secondary endpoint.
There was no association between the 3 opioid tools evaluated with the POIRD surrogate endpoint or escalation of care. Bipolar disorder (OR 3.68; 95% CI 1.11-9.56) and a history of substance abuse (OR 26.33; 95% CI 5.18-119.02) were significant risk factors that contributed to escalation of care secondary to respiratory failure. A history of substance abuse was found to have a significant association with escalation of care secondary to respiratory failure with naloxone administration (OR=6.886; 95% CI 2.02-23.56).
While we were unable to identify a tool to stratify POIRD risk; patients with bipolar disorder and a history of substance abuse are at an increased risk of postoperative respiratory failure requiring escalation of care; with a history of substance abuse being associated with POIRD.
术后阿片类药物引起的呼吸抑制(POIRD)是围手术期可预防的发病和死亡原因。一种经过验证的POIRD风险分层工具可以减少这些并发症。在这项回顾性病例对照研究中,对3种预先存在的经过验证的阿片类药物工具以及从这些工具中确定的特定风险因素进行了检查,以确定它们是否可以评估从麻醉后护理单元(PACU)出院到医院病房的患者的POIRD风险。
我们的数据集包括2019年1月至2021年12月在田纳西大学医学中心接受手术的126例匹配患者。所有与活动性创伤或烧伤相关的患者均被排除在本研究之外。因呼吸衰竭导致的护理升级(随着转移到重症监护病房/降级病房或因呼吸衰竭导致患者死亡而增加呼吸支持),无论是否使用纳洛酮,是主要终点;接受纳洛酮治疗的亚组是替代POIRD终点。因呼吸衰竭导致的护理升级,无论是否使用纳洛酮,是次要终点。
评估的3种阿片类药物工具与POIRD替代终点或护理升级之间没有关联。双相情感障碍(OR 3.68;95%CI 1.11-9.56)和药物滥用史(OR 26.33;95%CI 5.18-119.02)是导致因呼吸衰竭而护理升级的重要风险因素。发现药物滥用史与使用纳洛酮后因呼吸衰竭导致的护理升级有显著关联(OR=6.886;95%CI 2.02-23.56)。
虽然我们无法确定一种对POIRD风险进行分层的工具,但双相情感障碍患者和有药物滥用史的患者术后呼吸衰竭需要护理升级的风险增加,药物滥用史与POIRD相关。